{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:10:32Z","timestamp":1783015832391,"version":"3.54.6"},"reference-count":136,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2016.12.066","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T01:15:21Z","timestamp":1486430121000},"page":"5551-5558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Potential impact of a Moraxella catarrhalis vaccine in COPD"],"prefix":"10.1016","volume":"37","author":[{"given":"Antonia C.","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.12.066_b0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1574-6976.2010.00237.x","article-title":"Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease","volume":"35","author":"Doring","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.12.066_b0015","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.12.066_b0020","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.294.10.1255","article-title":"Trends in the leading causes of death in the United States, 1970\u20132002","volume":"294","author":"Jemal","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.12.066_b0025","unstructured":"World Health Organization. Chronic Respiratory Diseases, Burden of COPD; 2016."},{"key":"10.1016\/j.vaccine.2016.12.066_b0030","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0035","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1183\/09031936.00109906","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"29","author":"Celli","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM200007273430407","article-title":"Chronic obstructive pulmonary disease","volume":"343","author":"Barnes","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.201503-0534UP","article-title":"Update in chronic obstructive pulmonary disease 2014","volume":"192","author":"Seemungal","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm.164.3.2010017","article-title":"Lung Health Study Research Group. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study","volume":"164","author":"Kanner","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2016.12.066_b0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/COPD.S13826","article-title":"Association between lung function and exacerbation frequency in patients with COPD","volume":"5","author":"Hoogendoorn","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.04.00121404","article-title":"Impact of preventing exacerbations on deterioration of health status in COPD","volume":"23","author":"Spencer","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1378\/chest.130.1.133","article-title":"Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study","volume":"130","author":"Kessler","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2016.12.066_b0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00019053-200523040-00005","article-title":"Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature","volume":"23","author":"Doll","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2016.12.066_b0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2016.12.066_b0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2016.12.066_b0095","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1164\/rccm.201501-0044ST","article-title":"An Official American Thoracic Society\/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease","volume":"191","author":"Celli","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1164\/rccm.200412-1747OC","article-title":"Moraxella catarrhalis in chronic obstructive pulmonary disease. Burden of disease and immune response","volume":"172","author":"Murphy","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/599375","article-title":"Moraxella catarrhalis, a human respiratory tract pathogen","volume":"49","author":"Murphy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0120","first-page":"534","article-title":"The bacteriology of chronic bronchitis","volume":"12","author":"May","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.12.066_b0125","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/IAI.73.6.3471-3478.2005","article-title":"Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease","volume":"73","author":"Murphy","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0130","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1128\/IAI.73.12.8161-8166.2005","article-title":"Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease","volume":"73","author":"Murphy","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0135","series-title":"Harrison's Principles of Internal Medicine","first-page":"1228","article-title":"Haemophilus and Moraxella Infections","author":"Murphy","year":"2012"},{"key":"10.1016\/j.vaccine.2016.12.066_b0140","series-title":"Principles and Practice of Infectious Diseases","article-title":"Moraxella catarrhalis, Kingella, and Other Gram-Negative Cocci","author":"Murphy","year":"2015"},{"key":"10.1016\/j.vaccine.2016.12.066_b0145","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/IAI.00597-15","article-title":"Expression of the oligopeptide permease operon of Moraxella catarrhalis is regulated by temperature and nutrient availability","volume":"83","author":"Jones","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0150","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1128\/IAI.73.12.8247-8255.2005","article-title":"Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis","volume":"73","author":"Heiniger","year":"2005","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2016.12.066_b0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/COPD.S121389","article-title":"Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records","volume":"12","author":"Williams","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.vaccine.2016.12.066_b0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1183\/09031936.00194610","article-title":"Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study","volume":"39","author":"Jenkins","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1378\/chest.12-1277","article-title":"Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial","volume":"143","author":"Rabe","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2016.12.066_b0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1034\/j.1399-3003.1999.13d25.x","article-title":"Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease","volume":"13","author":"Donaldson","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S1473-3099(04)01177-6","article-title":"Seasonality of infectious diseases and severe acute respiratory syndrome-what we don't know can hurt us","volume":"4","author":"Dowell","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0180","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jinf.2013.09.003","article-title":"Infectious etiology of acute exacerbations in severe COPD patients","volume":"67","author":"Domenech","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.12.066_b0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12931-014-0114-1","article-title":"Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease","volume":"15","author":"Singh","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2016.12.066_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1378\/chest.14-0764","article-title":"Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations","volume":"147","author":"Barker","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2016.12.066_b0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jinf.2012.12.002","article-title":"Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media","volume":"66","author":"Ruohola","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.12.066_b0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/2049-632X.12129","article-title":"Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo","volume":"70","author":"Perez","year":"2014","journal-title":"Pathogens Disease"},{"key":"10.1016\/j.vaccine.2016.12.066_b0205","doi-asserted-by":"crossref","unstructured":"Armbruster CE, Hong W, Pang B, Weimer KE, Juneau RA, Turner J, et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio; 2010. p. 1.","DOI":"10.1128\/mBio.00102-10"},{"key":"10.1016\/j.vaccine.2016.12.066_b0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/000348941312200206","article-title":"Topographic distribution of biofilm-producing bacteria in adenoid subsites of children with chronic or recurrent middle ear infections","volume":"122","author":"Torretta","year":"2013","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.296.2.202","article-title":"Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media","volume":"296","author":"Hall-Stoodley","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.12.066_b0220","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/AAC.01772-10","article-title":"Moraxella catarrhalis outer membrane vesicles carry beta-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin","volume":"55","author":"Schaar","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2016.12.066_b0225","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/517611","article-title":"Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles","volume":"195","author":"Tan","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0230","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/jmv.22221","article-title":"High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media","volume":"83","author":"Wiertsema","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jinf.2015.06.010","article-title":"Nasopharyngeal bacterial burden and antibiotics: influence on inflammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis","volume":"71","author":"Suarez-Arrabal","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.12.066_b0240","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3555","article-title":"Acute otitis media and other complications of viral respiratory infection","volume":"137","author":"Chonmaitree","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.12.066_b0245","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1096\/fj.201500172R","article-title":"Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells","volume":"30","author":"Heinrich","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0250","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/INF.0000000000000800","article-title":"Role of nasopharyngeal bacteria and respiratory viruses in acute symptoms of young children","volume":"34","author":"Uitti","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/INF.0000000000000733","article-title":"Bacterial and respiratory viral interactions in the etiology of acute otitis media in HIV-infected and HIV-uninfected South African Children","volume":"34","author":"Madhi","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0260","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1183\/09031936.00223113","article-title":"Human rhinovirus infection during naturally occurring COPD exacerbations","volume":"44","author":"George","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmicb.2013.00293","article-title":"Virus-induced exacerbations in asthma and COPD","volume":"4","author":"Kurai","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0270","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.12.066_b0275","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/resp.12099","article-title":"Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission","volume":"18","author":"Wark","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.vaccine.2016.12.066_b0280","doi-asserted-by":"crossref","first-page":"e40088","DOI":"10.1371\/journal.pone.0040088","article-title":"Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media","volume":"7","author":"Brockson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.12.066_b0285","first-page":"1","article-title":"Replication of type 5 adenovirus promotes middle ear infection by Streptococcus pneumoniae in the chinchilla model of otitis media","volume":"73","author":"Murrah","year":"2015","journal-title":"Pathog Dis."},{"key":"10.1016\/j.vaccine.2016.12.066_b0290","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1462-5822.2009.01339.x","article-title":"Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae","volume":"11","author":"McGillivary","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0295","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1128\/JVI.79.10.6035-6042.2005","article-title":"Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus","volume":"79","author":"Gitiban","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0300","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/IAI.01856-14","article-title":"Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation","volume":"82","author":"Wren","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0305","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1172\/JCI57762","article-title":"Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice","volume":"121","author":"Nakamura","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.12.066_b0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chom.2014.06.005","article-title":"Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source","volume":"16","author":"Siegel","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2016.12.066_b0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands","volume":"34","author":"Bosch","year":"2016","journal-title":"Vaccine"},{"issue":"Suppl S2","key":"10.1016\/j.vaccine.2016.12.066_b0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkf506","article-title":"Dynamics of nasopharyngeal colonization by potential respiratory pathogens","volume":"50","author":"Garcia-Rodriguez","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2016.12.066_b0325","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/00016489.2014.890291","article-title":"Risk factors for carriage of AOM pathogens during the first 3 years of life in children with early onset of acute otitis media","volume":"134","author":"Gisselsson-Solen","year":"2014","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0330","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1128\/IAI.00314-10","article-title":"Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen","volume":"79","author":"Yang","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0335","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1128\/IAI.01253-07","article-title":"Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection","volume":"76","author":"Ruckdeschel","year":"2008","journal-title":"Infect Immun"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.12.066_b0340","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0264-410X(00)00287-5","article-title":"Vaccines for Moraxella catarrhalis","volume":"19","author":"McMichael","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0345","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/978-1-4939-3387-7_25","article-title":"Approach to the discovery, development, and evaluation of a novel Neisseria meningitidis Serogroup B Vaccine","volume":"1403","author":"Green","year":"2016","journal-title":"Meth Mol Biol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0350","first-page":"137","article-title":"Molecular aspects of Bordetella pertussis pathogenesis","volume":"2","author":"Locht","year":"1999","journal-title":"Int Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0355","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/IAI.00799-15","article-title":"The vaccine candidate substrate binding protein SBP2 plays a key role in arginine uptake, which is required for growth of Moraxella catarrhalis","volume":"84","author":"Otsuka","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0360","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1128\/IAI.01832-14","article-title":"Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis","volume":"82","author":"Otsuka","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0365","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0370","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/infdis\/160.6.999","article-title":"Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae","volume":"160","author":"Faden","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0375","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3476(80)80182-X","article-title":"Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae","volume":"97","author":"Shurin","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.12.066_b0380","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10156-013-0601-1","article-title":"Pneumococcal vaccine and opsonic pneumococcal antibody","volume":"19","author":"Song","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2016.12.066_b0385","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/314845","article-title":"Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0390","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1086\/422155","article-title":"Immunization with the truncated adhesin Moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance","volume":"190","author":"Forsgren","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0395","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.vaccine.2004.02.027","article-title":"Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4\/rLP6\/UspA2 proteins combined with aqueous formulation of RC529","volume":"22","author":"Mason","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0400","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1086\/314501","article-title":"Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model","volume":"178","author":"Murphy","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0405","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1128\/IAI.73.5.2790-2796.2005","article-title":"Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis","volume":"73","author":"Yu","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2011.00013","article-title":"Mucosal immunization with the Moraxella catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis","volume":"2","author":"Easton","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0415","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.micinf.2013.02.004","article-title":"Impact of sequence diversity in the Moraxella catarrhalis UspA2\/UspA2H head domain on vitronectin binding and antigenic variation","volume":"15","author":"Su","year":"2013","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.12.066_b0420","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/JB.182.5.1364-1373.2000","article-title":"The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro","volume":"182","author":"Lafontaine","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0425","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/505581","article-title":"The respiratory pathogen Moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2","volume":"194","author":"Tan","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0430","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1128\/IAI.00310-15","article-title":"Moraxella catarrhalis binds plasminogen to evade host innate immunity","volume":"83","author":"Singh","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0435","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1365-2958.2010.07066.x","article-title":"Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity","volume":"75","author":"Singh","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0440","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1128\/JB.01204-06","article-title":"A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein","volume":"188","author":"Attia","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0445","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1016\/j.vaccine.2007.04.026","article-title":"Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis","volume":"25","author":"Mawas","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0450","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/165.4.644","article-title":"Pulmonary clearance of Moraxella catarrhalis in an animal model","volume":"165","author":"Unhanand","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0455","doi-asserted-by":"crossref","first-page":"e67881","DOI":"10.1371\/journal.pone.0067881","article-title":"Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2","volume":"8","author":"Shaffer","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.12.066_b0460","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/IAI.00946-07","article-title":"Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation","volume":"75","author":"Luke","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0465","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2958.2011.07831.x","article-title":"RbsB (NTHI_0632) mediates quorum signal uptake in nontypeable Haemophilus influenzae strain 86\u2013028NP","volume":"82","author":"Armbruster","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0470","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.vaccine.2006.03.021","article-title":"Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae","volume":"24","author":"Novotny","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0475","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftu011","article-title":"Nonencapsulated Streptococcus pneumoniae causes otitis media during single-species infection and during polymicrobial infection with nontypeable Haemophilus influenzae","volume":"73","author":"Murrah","year":"2015","journal-title":"Pathog Dis."},{"key":"10.1016\/j.vaccine.2016.12.066_b0480","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/infdis\/jiw062","article-title":"Immunoinformatics identifies a lactoferrin binding Protein A peptide as a promising vaccine with a global protective prospective against Moraxella catarrhalis","volume":"213","author":"Yassin","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0485","doi-asserted-by":"crossref","first-page":"e29553","DOI":"10.1371\/journal.pone.0029553","article-title":"Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.12.066_b0490","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1128\/IAI.01081-06","article-title":"Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model","volume":"75","author":"Becker","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0495","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.4049\/jimmunol.167.4.2112","article-title":"Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis","volume":"167","author":"Forsgren","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0500","doi-asserted-by":"crossref","first-page":"445","DOI":"10.18388\/abp.2006_3315","article-title":"MID and UspA1\/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development","volume":"53","author":"Riesbeck","year":"2006","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0505","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/IAI.73.8.5127-5136.2005","article-title":"Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells","volume":"73","author":"Bullard","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0510","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/CVI.00460-08","article-title":"Identification of domains of the Hag\/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis","volume":"16","author":"LaFontaine","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0515","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1016\/j.vaccine.2011.06.019","article-title":"Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants","volume":"29","author":"Verhaegh","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0520","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/IAI.00396-07","article-title":"Identification of a novel two-partner secretion locus in Moraxella catarrhalis","volume":"75","author":"Plamondon","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0525","unstructured":"Balder R, Shaffer T, Wiese L, LaFontaine ER. Vaccination with Moraxella catarrhalis MhaB1\/B2 proteins enhance clearance in a chinchilla nasopharyngeal colonization model. American Society for Microbiology General Meeting. New Orleans LA 2011. p. 129."},{"key":"10.1016\/j.vaccine.2016.12.066_b0530","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1574-6968.2006.00549.x","article-title":"Identification of a Moraxella catarrhalis gene that confers adherence to various human epithelial cell lines in vitro","volume":"267","author":"Lipski","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2016.12.066_b0535","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1128\/IAI.00314-10","article-title":"Characterization and evaluation of the Moraxella catarrhalis oligopeptide Permease A as a mucosal vaccine antigen","volume":"79","author":"Yang","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0540","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1128\/IAI.02185-14","article-title":"Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract","volume":"82","author":"Jones","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0545","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1016\/j.vaccine.2015.09.023","article-title":"Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children","volume":"33","author":"Ren","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0550","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1016\/j.vaccine.2009.09.062","article-title":"Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis","volume":"27","author":"Ruckdeschel","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0555","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/IAI.01330-06","article-title":"The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain","volume":"75","author":"Lipski","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0560","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/IAI.71.8.4341-4350.2003","article-title":"Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities","volume":"71","author":"Timpe","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0565","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/IAI.67.3.1310-1316.1999","article-title":"The levels and bactericidal capacity of antibodies directed against theUspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children","volume":"67","author":"Chen","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0570","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/IAI.69.6.3576-3580.2001","article-title":"Conservation of outer membrane protein E among strains of Moraxella catarrhalis","volume":"69","author":"Murphy","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0575","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1128\/IAI.68.11.6250-6256.2000","article-title":"Outer membrane protein E of Moraxella catarrhalis: antigenic structure and construction and characterization of mutants","volume":"168","author":"Murphy","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0580","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2958.1993.tb00906.x","article-title":"The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis","volume":"10","author":"Murphy","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0585","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0882-4010(95)90272-4","article-title":"Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract","volume":"19","author":"Hsiao","year":"1995","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.vaccine.2016.12.066_b0590","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/IAI.67.9.4578-4585.1999","article-title":"Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis","volume":"67","author":"Murphy","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0595","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/IAI.00074-07","article-title":"Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model","volume":"75","author":"Liu","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0600","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1128\/IAI.71.3.1288-1294.2003","article-title":"Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease","volume":"71","author":"Murphy","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0605","doi-asserted-by":"crossref","first-page":"e64422","DOI":"10.1371\/journal.pone.0064422","article-title":"Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model","volume":"8","author":"Smidt","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.12.066_b0610","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1016\/j.vaccine.2016.05.045","article-title":"Sulfate-binding Protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis","volume":"34","author":"Murphy","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0615","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1128\/JB.187.18.6528-6535.2005","article-title":"Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop","volume":"187","author":"Easton","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0620","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1128\/JB.01039-08","article-title":"Moraxella catarrhalis M35 is a general porin that is important for growth under nutrient-limiting conditions and in the nasopharynges of mice","volume":"190","author":"Easton","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0625","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2011.00013","article-title":"Mucosal immunization with Moraxella catarrhalis porin M35 induces enhanced bacterial clearance from the lung: a possible role for phagocytosis","volume":"2","author":"Easton","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0630","doi-asserted-by":"crossref","first-page":"e0158689","DOI":"10.1371\/journal.pone.0158689","article-title":"ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence","volume":"11","author":"Murphy","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.12.066_b0635","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.vaccine.2003.12.016","article-title":"Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis","volume":"22","author":"Adlowitz","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.066_b0640","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1128\/IAI.73.10.6601-6607.2005","article-title":"Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis","volume":"73","author":"Adlowitz","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0645","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1574-695X.2005.00020.x","article-title":"Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease","volume":"46","author":"Adlowitz","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0650","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/infdis\/jiu241","article-title":"Outer membrane protein OlpA contributes to Moraxella catarrhalis serum resistance via interaction with factor H and the alternative pathway","volume":"210","author":"Bernhard","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.066_b0655","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JB.00788-06","article-title":"Characterization of the Moraxella catarrhalis opa-like protein, OlpA, reveals a phylogenetically conserved family of outer membrane proteins","volume":"189","author":"Brooks","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0660","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2011.01.010","article-title":"Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA","volume":"477","author":"Luke-Marshall","year":"2011","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2016.12.066_b0665","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.femsim.2004.02.001","article-title":"Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates","volume":"41","author":"Hu","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.12.066_b0670","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/IAI.01915-06","article-title":"Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis","volume":"75","author":"Yu","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.12.066_b0675","doi-asserted-by":"crossref","DOI":"10.1007\/s10719-011-9332-7","article-title":"Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera","author":"Cox","year":"2011","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2016.12.066_b0680","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.vaccine.2011.03.102","article-title":"Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis","volume":"29","author":"Ren","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16313007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16313007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T23:28:03Z","timestamp":1601594883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16313007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":136,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X16313007"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential impact of a Moraxella catarrhalis vaccine in COPD","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}